SCI Pharmtech, Inc. (TPE: 4119)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
84.80
+0.60 (0.71%)
Jan 20, 2025, 1:30 PM CST

SCI Pharmtech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
10,13411,5689,3008,0126,6778,454
Upgrade
Market Cap Growth
4.31%24.39%16.07%20.00%-21.02%50.44%
Upgrade
Enterprise Value
10,69412,2189,1716,9916,2027,629
Upgrade
Last Close Price
84.8095.4683.9672.3359.9574.41
Upgrade
PE Ratio
20.7839.2530.12143.8518.5414.80
Upgrade
Forward PE
-29.3439.47108.50-14.14
Upgrade
PS Ratio
7.109.6110.349.272.483.59
Upgrade
PB Ratio
1.872.272.562.412.012.43
Upgrade
P/TBV Ratio
1.992.292.602.462.042.47
Upgrade
P/FCF Ratio
----8.8614.28
Upgrade
P/OCF Ratio
111.6653.6231.3628.596.8710.68
Upgrade
EV/Sales Ratio
7.5710.1510.198.092.313.24
Upgrade
EV/EBITDA Ratio
29.9040.2344.1051.565.249.17
Upgrade
EV/EBIT Ratio
75.9976.2277.0994.915.9010.94
Upgrade
EV/FCF Ratio
-15.35---8.2312.89
Upgrade
Debt / Equity Ratio
0.200.200.150.000.000.00
Upgrade
Debt / EBITDA Ratio
2.933.412.600.020.000.00
Upgrade
Debt / FCF Ratio
----0.000.01
Upgrade
Asset Turnover
0.220.210.200.200.620.60
Upgrade
Inventory Turnover
1.821.641.511.943.122.76
Upgrade
Quick Ratio
1.562.350.611.391.332.35
Upgrade
Current Ratio
2.353.431.351.871.713.31
Upgrade
Return on Equity (ROE)
10.14%6.75%8.89%1.68%10.60%17.09%
Upgrade
Return on Assets (ROA)
1.56%1.72%1.63%1.05%15.19%11.07%
Upgrade
Return on Capital (ROIC)
1.73%1.94%1.98%1.39%19.32%13.03%
Upgrade
Earnings Yield
4.81%2.55%3.32%0.70%5.39%6.76%
Upgrade
FCF Yield
-6.88%-7.03%-9.37%-6.13%11.29%7.00%
Upgrade
Dividend Yield
1.48%1.31%0.26%-0.62%5.77%
Upgrade
Payout Ratio
30.85%8.09%-71.36%128.02%58.46%
Upgrade
Buyback Yield / Dilution
-10.21%-1.87%-0.08%0.49%0.26%0.07%
Upgrade
Total Shareholder Return
-8.72%-0.56%0.19%0.49%0.87%5.84%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.